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pregnancy. Degree of lag depends on the severity of IUGR - 31%
of normal in FGR III degree. When PI there is a decrease in
vascular resistance in the thyroid arteries - by 22.2% from the
norm in FGR III degree. In FGR II-III degree decreases the
concentration of thyroid hormones and increased TSH: T3 total
was reduced by 22%, total T4 - 66.7%, TSH increased - by 42%.
In FGR II-III degree a marked lag growth adrenal compared with
uncomplicated pregnancy - 25.3% width, 26% height and 15.5% in
thickness. In FGR I degree the growth of vascular resistance
occurs in the adrenal arteries - 16% of normal. In FGR III degree -
reducing vascular resistance - 27% of normal.
Conclusions: In FGR II-III degree decreases the concentration of
cortisol in the blood of a newborn - below 105 nmol/L, indicating that
violations of adaptation followed by the appearance of severe
complications in the early neonatal and postnatal periods.
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Brief Introduction: Overweight is a rising problem worldwide. It
increases the risk of various pathologies, including those related to
pregnancy and childbirth. Plasminogen activator inhibitor-1 (PAI-1)
plays an important role in a pathogenesis of variety of overweight-
related diseases.
The aim of this study is to determine PAI-1 concentration in
maternal plasma of pregnant women with and without overweight,
follow the changes during the first and second trimesters, and to find
out whether there is a correlation between PAI-1 and childbirth
complications.
Materials & Methods: It is a prospective study involving pregnant
women at their first antenatal visit. According to body mass index
(BMI), the patients were divided into groups with (n=20) and without
overweight (n= 41). At 9th-12th, 15th-18th and 24th-28th weeks of
pregnancy plasma samples were collected and PAI-1 concentrations
was established using Luminex-200 system. From the medical records
clinical data on parturition were collected. Statistical analysis was
carried out by programms R and LibreOffice Calc.
Clinical Cases or Summary Results: During pregnancy PAI-1 plasma
concentration is gradually rising, and it is higher in women with
excessive weight. Statistically significant differences were found
between PAI-1 levels in patients with normal BMI and with or
without fetal macrosomia - maternal cytokine concentration was
higher when fetal macrosomia was found, and this relationship
persists in both first and second trimester.
Conclusions: PAI-1 concentrations in the plasma of pregnant women
starts to increase from the first trimester and is significantly higher in
women with excessive weight. In addition, PAI-1 concentrations
statistically significantly correlate with risk of fetal macrosomia in
normal BMI patients.
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Brief Introduction: Many lines of research require further development
for the purpose of better understanding the mechanisms of fetal
programming, clarifying the role of maternal nutrition, and more
importantly, determining whether impaired fetal growth could have
potentially adverse effects on chronic disease at an adult age.
Low birth-weight, due to preterm birth or foetal growth restriction, is
a marker of a lack of nutrients during ‘‘critical’’ periods of rapid
cell division, that could programme the immune system.
According to this new epigenetic developmental model, the aim
of our study was to evaluate whether a significant correlation
exists between low birth weight, other perinatal variables and the
subsequent development of systemic sclerosis (SSc), a chronic
systemic autoimmune disease.
Materials & Methods: During the period from June 2012 to November
2013, a multicenter case-control study was conducted with 332
consecutive prevalent cases of SSc and 243 controls, asking them to
fill out a questionnaire regarding their demographic and perinatal
information: gender, age, birth-weight, gestational age at birth, their
mother’s age at birth, breastfeeding, mother’s smoke habit. A sub-
sample of 40 cases and 40 controls was re-questioned later to verify
the accuracy of the first response. Birth-weight was always treated as
a dichotomous variable (52500 g vs. !2500 g), low birth-weight was
defined as weight less than 2500 g and small for gestational age was
defined as a weight52500 g in patients born at term. The association
between both low birth-weight and small for gestational age with
systemic sclerosis was expressed with the crude (univariate analysis)
and adjusted (multivariate analysis) odds ratio.
Clinical Cases or Summary Results: Low birth weight infants (52500 gr)
had an increased risk of SSc when compared with higher birth weight
infants (!2500) (OR 2.59, 95% CI 1.39 to 5.05). When the analysis was
limited to female subjects only, this value increased to an OR of 2.90.
A similar result was found when we considered the exposure to small
for gestational age (SGA) status (OR 2.60, 95% CI 1.34 to 5.32, that
increases to 2.73, 95% CI 1.38 to 5.73 in female subjects).
In the multivariate analysis, the odds of disease in the low birth-
weight female group was approximately 4 fold higher than in the
normal birth-weight group.
Conclusions: Our study documents that the risk of developing SSc is
higher when the patient was a LBW newborn. The precise cellular and
molecular mechanisms which could explain the correlation between
SSc and weight at birth, remain poorly understood. Environmental
agents including, maternal diet or illness, endocrine disruptors or
exposure to toxic levels of chemical agents, could act epigenetic
mechanisms and cause modifications to the fetal immune system
with the result of altering the phenotype in the off spring.
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